Darwin Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2K Buy
118
+39
+49% +$4.57K ﹤0.01% 350
2026
Q1
$9.52K Hold
79
﹤0.01% 364
2025
Q4
$8.33K Sell
79
-228
-74% -$21.4K ﹤0.01% 392
2025
Q3
$25.8K Buy
307
+216
+237% +$17.8K 0.01% 272
2025
Q2
$7.28K Sell
91
-208
-70% -$16.5K ﹤0.01% 376
2025
Q1
$29.8K Hold
299
0.01% 266
2024
Q4
$29.8K Buy
299
+21
+8% +$2.17K 0.01% 266
2024
Q3
$31.5K Buy
+278
New +$33K 0.01% 266
2023
Q1
Sell
-13,624
Closed -$1.53M 172
2022
Q4
$1.53M Buy
+13,624
New +$1.39M 0.4% 55
2021
Q3
Sell
-3,275
Closed -$255K 180
2021
Q2
$255K Buy
3,275
+391
+14% +$29.1K 0.04% 153
2021
Q1
$212K Buy
2,884
+48
+2% +$3.54K 0.04% 156
2020
Q4
$221K Sell
2,836
-234
-8% -$17.9K 0.04% 152
2020
Q3
$243K Buy
3,070
+81
+3% +$6.34K 0.05% 139
2020
Q2
$220K Sell
2,989
-268
-8% -$20.2K 0.06% 146
2020
Q1
$238K Buy
+3,257
New +$256K 0.08% 116

Other funds holding MRK

Darwin Wealth Management's MRK Position: Q2 2026 in Review

Darwin Wealth Management increased its Merck (MRK) stake by 49% in Q2 2026, buying an estimated $4.57K and bringing the position to 118 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #350.

Darwin Wealth Management first reported a position in MRK in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.53M in Q4 2022. 1,458 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Darwin Wealth Management held 118 shares of Merck worth $15.2K as of Q2 2026.
  • Darwin Wealth Management bought 39 Merck shares in Q2 2026, an estimated $4.57K.
  • Merck made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #350 holding.
  • Darwin Wealth Management first reported a position in Merck in Q1 2020 and has held it in 15 quarters since.
  • Darwin Wealth Management's Merck position peaked at $1.53M in Q4 2022.
  • 1,458 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.